The global breast biopsy market to grow at a CAGR of 10.70% during the period 2017-2021.
A breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer.
The report, Global Breast Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one of the major drivers for this market is growing incidence of breast cancer. The rising incidence of breast cancer is fueling the growth of the breast biopsy market worldwide. Breast cancer is the most common cancer prevalent in females and is the second most common cancer overall, after skin cancer. Breast cancer is found to affect men above 50 years of age and is rare in young women.
- C.R. Bard
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Breast cancer: An overview
PART 06: Market landscape
PART 07: Market segmentation by product type
PART 08: Market segmentation by modality
PART 09: Market segmentation by end-user
PART 10: Geographical segmentation
PART 11: Decision framework
PART 12: Drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/fmt4rt/global_breast